Published • loading... • Updated
This $15 Billion Operational Beat Just Rewrote the Entire Bear Thesis for AbbVie
Summary by 247wallst.com
1 Articles
1 Articles
This $15 Billion Operational Beat Just Rewrote the Entire Bear Thesis for AbbVie
The post This $15 Billion Operational Beat Just Rewrote the Entire Bear Thesis for AbbVie appeared first on 24/7 Wall St.. AbbVie (ABBV) posted Q1 revenue of $15.002B (beating consensus by $284M) with a 65.4% free cash flow payout ratio and 13-year dividend streak, supporting its 2.98% yield. Skyrizi and Rinvoq are replacing low-margin Humira faster than expected, with strong guidance raised to $14.28 adjusted EPS supporting AbbVie's dividend …
·New York, United States
Read Full Article
Father's Day SaleGet 40% off Vantage subscriptions for yourself or a friend.Get Started
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
